RecruitingNCT07148700

Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment

Sponsor

Bezmialem Vakif University

Enrollment

40 participants

Start Date

May 1, 2025

Study Type

OBSERVATIONAL

Conditions

Parkinson Disease Parkinson PARKINSON DISEASE (Disorder)Parkinson's Disease Parkinson Disease (PD)

Summary

Introduction: Falls are common in Parkinson's disease (PD), affecting 30-90% of patients annually, with more than half experiencing recurrent falls. Identifying balance assessment tools that are both practical and predictive of fall risk is therefore essential. This study aimed to investigate the relationship between fall frequency and three balance assessment tools: the Biodex Balance System (objective), the Falls Efficacy Scale-International (FES-I) (self-reported), and the Mini-Balance Evaluation Systems Test (Mini-BESTest) (functional). Methods: Patients with PD at Hoehn and Yahr stages 1-3 will be included in the study. Fall data will be collected using a fall diary, while objective balance will be assessed with the Biodex Balance System, functional performance will be evaluated with the Mini-BESTest, and self-reported balance confidence will be measured with the FES-I.

Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing different tools for predicting fall risk in people with Parkinson's disease. Falls are a major concern for Parkinson's patients, and researchers want to find out which assessment methods — objective tests, balance tests, or self-reported questionnaires — predict falls most accurately. **You may be eligible if...** - You are between 40 and 80 years old - You have been diagnosed with Parkinson's disease - You are on a stable dopamine medication regimen - You have no other neurological disorders - Your mental status score is above 24 on a standard test (MMSE) - Your Parkinson's disease is at a mild to moderate stage (Hoehn and Yahr stage 1–3) **You may NOT be eligible if...** - You have significant vision, hearing, cardiovascular, or lung problems - You have had a clinically unstable condition in the past month - You have participated in a rehabilitation program in the last 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Bezmialem Vakif University

Istanbul, Eyup, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07148700

Related Trials

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

NCT065536254 locations

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

NCT0207113484 locations

Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder

NCT058931861 location

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

NCT0366460919 locations

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease

NCT055684981 location